Capstone Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.77M Sell
70,221
-2,640
-4% -$96.4K 0.08% 309
2017
Q1
$2.29M Sell
72,861
-2,334
-3% -$73.1K 0.06% 362
2016
Q4
$2.35M Sell
75,195
-4,914
-6% -$159K 0.07% 337
2016
Q3
$3.22M Buy
80,109
+1,020
+1% +$38.4K 0.09% 262
2016
Q2
$2.63M Buy
79,089
+7,296
+10% +$250K 0.08% 299
2016
Q1
$2.11M Sell
71,793
-3,480
-5% -$96K 0.06% 372
2015
Q4
$1.98M Buy
75,273
+6,723
+10% +$175K 0.06% 398
2015
Q3
$1.62M Buy
68,550
+1,770
+3% +$42.7K 0.05% 422
2015
Q2
$1.58M Sell
66,780
-10,134
-13% -$229K 0.05% 451
2015
Q1
$1.83M Buy
76,914
+3,120
+4% +$70K 0.05% 422
2014
Q4
$1.57M Buy
73,794
+35,820
+94% +$720K 0.05% 461
2014
Q3
$647K Buy
37,974
+240
+0.6% +$3.79K 0.02% 838
2014
Q2
$540K Sell
37,734
-11,454
-23% -$155K 0.02% 1006
2014
Q1
$608K Sell
49,188
-8,400
-15% -$96.9K 0.02% 916
2013
Q4
$631K Sell
57,588
-46,950
-45% -$529K 0.02% 935
2013
Q3
$1.21M Sell
104,538
-888
-0.8% -$10.4K 0.03% 663
2013
Q2
$1.18M Buy
+105,426
New +$1.25M 0.03% 628

Other funds holding EW

Capstone Asset Management's EW Position: Q2 2017 in Review

Capstone Asset Management reduced its Edwards Lifesciences (EW) stake by 3.6% in Q2 2017, selling an estimated $96.4K and leaving 70,221 shares worth $2.77M. The position accounts for 0.08% of the portfolio, ranked #309.

Capstone Asset Management first reported a position in EW in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.22M in Q3 2016. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Capstone Asset Management held 70,221 shares of Edwards Lifesciences worth $2.77M as of Q2 2017.
  • Capstone Asset Management sold 2,640 Edwards Lifesciences shares in Q2 2017, an estimated $96.4K.
  • Edwards Lifesciences made up 0.08% of Capstone Asset Management's portfolio in Q2 2017, its #309 holding.
  • Capstone Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Edwards Lifesciences position peaked at $3.22M in Q3 2016.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.